Chemo patch for skin cancer shows promise in early trial
Disease control
Terminated
This early-stage study tested a new way to deliver the chemotherapy drug doxorubicin directly into basal cell skin cancer using tiny dissolving needles on a patch. The goal was to find a safe dose and see if it could completely remove the cancer. The study included 13 adults with…
Phase: PHASE1 • Sponsor: SkinJect, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC